Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 56Triple Negative Breast Neoplasms 28Lung Neoplasms 12Prostatic Neoplasms 10Neoplasm Metastasis 10Carcinoma, Intraductal, Noninfiltrating 10Anatomic Stage I Breast Cancer AJCC v8 9Carcinoma, Non-Small-Cell Lung 8Breast Carcinoma In Situ 8Ovarian Neoplasms 6Melanoma 6Stomach Neoplasms 5Pancreatic Neoplasms 5Meningeal Carcinomatosis 5Colorectal Neoplasms 5Carcinoma, Renal Cell 5Carcinoma, Hepatocellular 5Multiple Myeloma 4Colonic Neoplasms 4Brain Neoplasms 4Anatomic Stage IV Breast Cancer AJCC v8 4Small Cell Lung Carcinoma 3Inflammatory Breast Neoplasms 3Esophageal Neoplasms 3Endometrial Neoplasms 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Thyroid Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Obesity 2

Interventions

Specimen Handling 1Magnetic Resonance Spectroscopy 1Clinical Protocols 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Hormone Receptor-Positive Breast Carcinoma × Specimen Handling × Breast × Clear all
NCT07590583 2026-05-15

Biology Guided Therapy Recommendations for Treatment Determination of Hormone Receptor-Positive Advanced, Unresectable or Metastatic Breast Cancer, ENDORSE Trial

City of Hope Medical Center

Phase 1 Not yet recruiting
20 enrolled
Breast

Advanced Hormone Receptor-Positive Breast Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡